Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Industry Practices for Expedited Reporting to Investigators Conducting Research Under an IND.
Journal: Therapeutic innovation & regulatory science
Published: November 01, 2014
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application.
Journal: Therapeutic innovation & regulatory science
Published: March 01, 2014
Portfolio of clinical research in adult cardiovascular disease as reflected in ClinicalTrials.gov.
Journal: Journal of the American Heart Association
Published: September 28, 2013
Investigators' Experience With Expedited Safety Reports Prior to the FDA's Final IND Safety Reporting Rule.
Journal: Therapeutic innovation & regulatory science
Published: August 05, 2013
Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
Journal: Clinical trials (London, England)
Published: May 14, 2013
Participants' perspectives on safety monitoring in clinical trials.
Journal: Clinical trials (London, England)
Published: May 07, 2013
Using central IRBs for multicenter clinical trials in the United States.
Journal: PloS one
Published: August 30, 2012
Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Journal: JAMA
Published: May 03, 2012
Impediments to clinical research in the United States.
Journal: Clinical pharmacology and therapeutics
Published: February 10, 2012
National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
Journal: American heart journal
Published: January 30, 2006
Managing the risks of therapeutic products: proceedings of a workshop.
Journal: Pharmacoepidemiology and drug safety
Published: January 11, 2005
Showing 1-11 of 11
Last Updated: 09/26/2026